Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

FokI-dCas9 Citations (4)

Plasmid Article: Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification.
Guilinger JP, Thompson DB, Liu DR Nat Biotechnol. 2014 Apr 25. doi: 10.1038/nbt.2909.
PubMed Journal

Articles Citing FokI-dCas9

Generation of mutant mice via the CRISPR/Cas9 system using FokI-dCas9. Hara S, Tamano M, Yamashita S, Kato T, Saito T, Sakuma T, Yamamoto T, Inui M, Takada S. Sci Rep. 2015 Jun 9;5:11221. doi: 10.1038/srep11221. PubMed
Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9. Terao M, Tamano M, Hara S, Kato T, Kinoshita M, Takada S. Exp Anim. 2016 Mar 14. PubMed
CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model. Pan Y, Shen N, Jung-Klawitter S, Betzen C, Hoffmann GF, Hoheisel JD, Blau N. Sci Rep. 2016 Oct 27;6:35794. doi: 10.1038/srep35794. PubMed
Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors. Jubair L, Fallaha S, McMillan NAJ. Mol Ther. 2019 Dec 4;27(12):2091-2099. doi: 10.1016/j.ymthe.2019.08.012. Epub 2019 Aug 29. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.